J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients
E. Gomez-Dominguez,Javier P. Gisbert,J.A. Moreno-Monteagudo,Luisa García-Buey,Ricardo Moreno-Otero +4 more
TL;DR: Atorvastatin is a new 3‐hydroxy‐3‐metylglutaryl coenzyme A reductase inhibitor that reduces lipid serum levels.
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding: PPI therapy initiated prior to endoscopy
Grigorios I. Leontiadis,A Sreedharan,S Dorward,P Barton,Brendan Delaney,Colin W. Howden,M Orhewere,Javier P. Gisbert,VK Sharma,A Rostom,Paul Moayyedi,D. Forman +11 more
Journal ArticleDOI
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
Javier P. Gisbert,Xavier Calvet +1 more
TL;DR: Aliment Pharmacol Ther 2012; 35: 209–221
Journal ArticleDOI
Anemia and inflammatory bowel diseases.
TL;DR: The clinician caring for IBD patients should have a comprehensive knowledge of anemia, and apply recently published guidelines in clinical practice.
Journal ArticleDOI
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
Carme Loras,Javier P. Gisbert,Miguel Minguez,Olga Merino,Luis Bujanda,Cristina Saro,E. Domènech,Jesus Barrio,Montserrat Andreu,Ingrid Ordás,L. Vida,Guillermo Bastida,Ferrán González-Huix,M Piqueras,Daniel Ginard,Xavier Calvet,Ana Gutiérrez,Agueda Abad,Miquel Torres,Julián Panés,María Chaparro,I. Pascual,Mónica Rodríguez-Carballeira,Fernando Fernández-Bañares,Josep Maria Viver,Maria Esteve +25 more
TL;DR: Liver dysfunction in patients with IBD treated with immunosuppressants is more frequent and severe in those with HBV than in HCV carriers and is associated with combined immunOSuppression.